tiprankstipranks
Advertisement
Advertisement

HK:2181 Stock Latest News

Mabpharm Wins China Approval for Denosumab Osteoporosis Drug, Eyes Global Markets
Company AnnouncementsMabpharm Wins China Approval for Denosumab Osteoporosis Drug, Eyes Global Markets
4d ago
2181
Mabpharm Sets 2026 AGM, Seeks 10% Share Buyback Mandate
PremiumCompany Announcements
Mabpharm Sets 2026 AGM, Seeks 10% Share Buyback Mandate
2M ago
2181
Mabpharm Moves to Update Constitution for Treasury Shares and Digital Governance
PremiumCompany Announcements
Mabpharm Moves to Update Constitution for Treasury Shares and Digital Governance
3M ago
2181
Mabpharm Swings to Profit on Surging 2025 Revenue and Strong Gross Margins
PremiumCompany Announcements
Mabpharm Swings to Profit on Surging 2025 Revenue and Strong Gross Margins
3M ago
2181
Mabpharm Sets March 26 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Mabpharm Sets March 26 Board Meeting to Approve 2025 Annual Results
3M ago
2181
Mabpharm Limited Announces Board and Committee Restructuring
PremiumCompany AnnouncementsMabpharm Limited Announces Board and Committee Restructuring
7M ago
2181
Mabpharm Limited Updates Nomination Committee Terms
Premium
Company Announcements
Mabpharm Limited Updates Nomination Committee Terms
7M ago
2181
Mabpharm Limited Reports Strong Interim Financial Results for H1 2025
Premium
Company Announcements
Mabpharm Limited Reports Strong Interim Financial Results for H1 2025
10M ago
2181
Mabpharm Limited Schedules Board Meeting for Interim Results
PremiumCompany Announcements
Mabpharm Limited Schedules Board Meeting for Interim Results
10M ago
2181
Mabpharm Limited Announces Unanimous Approval of AGM Resolutions
PremiumCompany Announcements
Mabpharm Limited Announces Unanimous Approval of AGM Resolutions
12M ago
2181
Mabpharm Limited Announces 2025 Annual General Meeting and Share Repurchase Proposal
PremiumCompany Announcements
Mabpharm Limited Announces 2025 Annual General Meeting and Share Repurchase Proposal
1y ago
2181
Mabpharm Limited Reports Significant Revenue Growth Amidst Financial Challenges
PremiumCompany Announcements
Mabpharm Limited Reports Significant Revenue Growth Amidst Financial Challenges
1y ago
2181
Mabpharm Limited Schedules Board Meeting for Annual Results Review
PremiumCompany AnnouncementsMabpharm Limited Schedules Board Meeting for Annual Results Review
1y ago
2181
Mabpharm Gains Approval in Pakistan for Key Drug
Premium
Company Announcements
Mabpharm Gains Approval in Pakistan for Key Drug
1y ago
2181
Mabpharm Gains Indonesian Approval for Key Drug
Premium
Company Announcements
Mabpharm Gains Indonesian Approval for Key Drug
1y ago
2181
Mabpharm Ends Lease Early for Strategic Growth
PremiumCompany Announcements
Mabpharm Ends Lease Early for Strategic Growth
2y ago
2181
Mabpharm Limited Reports Mixed Mid-Year Results
PremiumCompany Announcements
Mabpharm Limited Reports Mixed Mid-Year Results
2y ago
2181
Mabpharm Limited Announces Upcoming Board Meeting
PremiumCompany Announcements
Mabpharm Limited Announces Upcoming Board Meeting
2y ago
2181
Mabpharm Limited Announces Leadership Reshuffle
PremiumCompany Announcements
Mabpharm Limited Announces Leadership Reshuffle
2y ago
2181
Mabpharm’s Core Drug CMAB008 Wins Approval in Peru
PremiumCompany AnnouncementsMabpharm’s Core Drug CMAB008 Wins Approval in Peru
2y ago
2181
Mabpharm’s Core Cancer Drug Wins China Approval
Premium
Company Announcements
Mabpharm’s Core Cancer Drug Wins China Approval
2y ago
2181
Mabpharm Limited Unanimous Approval at AGM
Premium
Company Announcements
Mabpharm Limited Unanimous Approval at AGM
2y ago
2181

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >